✦ LIBER ✦

Use of Chimeric Forms of Neuronal Nitric-Oxide Synthase as Dominant Negative Mutants

✍ Scribed by Yume T. Phung; Stephen M. Black

Book ID: 111743296
Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 392 KB
Volume: 48
Category: Article
ISSN: 1521-6543
DOI: 10.1080/713803520

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of Nitric Oxide Formation by

Inhibition of Nitric Oxide Formation by Neuronal Nitric Oxide Synthase by Quinones: Nitric Oxide Synthase as a Quinone Reductase †

✍ Kumagai, Yoshito; Nakajima, Hiromi; Midorikawa, Kazumi; Homma-Takeda, Shino; Shi 📂 Article 📅 1998 🏛 American Chemical Society 🌐 English ⚖ 76 KB

Nitroaromatic Amino Acids as Inhibitors

Nitroaromatic Amino Acids as Inhibitors of Neuronal Nitric Oxide Synthase

✍ Cowart, Marlon; Kowaluk, Elizabeth A.; Daanen, Jerome F.; Kohlhaas, Kathy L.; Al 📂 Article 📅 1998 🏛 American Chemical Society 🌐 English ⚖ 186 KB

4-Substituted Indazoles as New Inhibitor

4-Substituted Indazoles as New Inhibitors of Neuronal Nitric Oxide Synthase.

✍ Michel Boulouard; Pascale Schumann-Bard; Sabrina Butt-Gueulle; Elodie Lohou; Sil 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 21 KB 👁 2 views

Use of dominant negative mutants of the

Use of dominant negative mutants of the hepadnaviral core protein as antiviral agents

✍ P Scaglioni; M Melegari; M Takahashi; J R Chowdhury; J Wands 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB

needed to reduce the risk of developing chronic liver disease Chronic hepatitis B virus (HBV) infection is a major and HCC in chronic HBV carriers. Current established thercause of acute and chronic liver diseases. We have reapy involves treatment with interferon alfa but results in cently described

Use of dominant negative mutants of the

Use of dominant negative mutants of the hepadnaviral core protein as antiviral agents

✍ P Scaglioni; M Melegari; M Takahashi; JR Chowdhury; J Wands 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

Use of dominant negative mutants of the

Use of dominant negative mutants of the hepadnaviral core protein as antiviral agents

✍ SCAGLIONI, P 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB